NCT04582448View on ClinicalTrials.gov

A Study Looking at How Insulin Icodec is Taken up in the Blood When Administered in Different Injection Sites in People With Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

September 27, 2021

Study Completion Date

September 27, 2021

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Insulin icodec

A single dose of insulin icodec administered subcutaneously (s.c. - under the skin) Injection in the belly, upper arm and thigh on different occasions.

Trial Locations (1)

55116

Novo Nordisk Investigational Site, Mainz